COVID-19 vaccination in pregnant and lactating diabetic women

被引:12
|
作者
Sculli, Maria Angela [1 ,2 ]
Formoso, Gloria [1 ,3 ]
Sciacca, Laura [1 ,4 ]
机构
[1] Italian Assoc Diabetologists AMD, Interassociat Diabet & Pregnancy Study Grp, Italian Soc Diabetol SID, Rome, Italy
[2] UOC Diabetol Endocrinol, Grande Osped Metropolitano Bianchi Melacrino Mor, Reggio Di Calabria, Italy
[3] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Ctr Adv Studies & Technol CAST, Ex CeSIMet, Chieti, Italy
[4] Univ Catania, Med Sch, Dept Clin & Expt Med, Endocrinol Sect, Catania, Italy
关键词
Gestational diabetes; Diabetes mellitus type 1; Diabetes mellitus type 2; COVID-19; Pregnancy; Vaccines;
D O I
10.1016/j.numecd.2021.04.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To discuss available information on the opportunity for pregnant women affected by diabetes/obesity to receive COVID-19 vaccine. Data synthesis: Pregnant women with SARS-CoV-2 (COVID-19) infection are at high risk for severe acute respiratory syndrome and adverse outcomes. Pregnant women with severe COVID19 present increased rates of preterm delivery (<37 gestational weeks), cesarean delivery and neonatal admissions to the intensive care unit. Comorbidity such as diabetes (pregestational or gestational) or obesity further increased maternal and fetal complications. It is known that diabetic or obese patients with COVID-19 present an unfavorable course and a worse prognosis, with a direct association between worse outcome and suboptimal glycol-metabolic control or body mass index (BMI) levels. Critical COVID-19 infection prevention is important for both mother and fetus. Vaccination during pregnancy is a common practice. Vaccines against COVID-19 are distributed across the world with some population considered to have a priority. Since pregnant women are excluded from clinical trials very little information are available on safety and efficacy of COVD-19 vaccines during pregnancy. However, it is well known the concept of passive immunization of the newborn obtained with transplacental passage of protective antibodies into the fetal/neonatal circulation after maternal infection or vaccination. Moreover, it has been reported that COVID-19 vaccine-induced IgG pass to the neonates through breastmilk. Therefore, maternal vaccination can protect mother, fetus and baby. Conclusions: After an individual risk/benefit evaluation pregnant and lactating women should be counselled to receive COVID-19 vaccines. (c) 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2151 / 2155
页数:5
相关论文
共 50 条
  • [21] Impact of provider relationship and trust on COVID-19 vaccination in pregnant and lactating individuals
    Thelen, Julia
    Binger, Kole S.
    Cui, Yiwen
    Palatnik, Anna
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S336 - S336
  • [22] COVID-19 Vaccination of Pregnant Women and Women with the Desire to have Children
    Zoellkau, Janine
    Pecks, Ulrich
    Schleussner, Ekkehard
    Scharl, Anton
    Abou-Dakn, Michael
    Kehl, Sven
    Hagenbeck, Carsten
    Albring, C.
    Schlembach, Dietmar
    Baston-Buest, Dunja
    Thaler, C.
    Saenger, Nicole
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (04) : 379 - +
  • [23] Sources of COVID-19 Vaccine Promotion for Pregnant and Lactating Women in Bangladesh
    Fesshaye, Berhaun
    Wade, Sydney A.
    Lee, Clarice
    Singh, Prachi
    Zavala, Eleonor
    Ali, Hasmot
    Rahman, Hafizur
    Siddiqua, Towfida Jahan
    Atker, Shirina
    Karron, Ruth A.
    Limaye, Rupali J.
    [J]. VACCINES, 2023, 11 (08)
  • [24] Alignment of national COVID-19 vaccine recommendations for pregnant and lactating women
    Giles, Michelle L.
    Gunatilaka, Ahinsa
    Palmer, Kirsten
    Sharma, Ketaki
    Roach, Vijay
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2021, 99 (10) : 739 - 746
  • [25] Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
    Chayachinda, Chenchit
    Watananirun, Kanokwaroon
    Phatihattakorn, Chayawat
    Anuwutnavin, Sanitra
    Niyomnaitham, Suvimol
    Phongsamart, Wanatpreeya
    Lapphra, Keswadee
    Wittawatmongkol, Orasri
    Rungmaitree, Supattra
    Jansarikit, Laddawan
    Boonnak, Kobporn
    Wongprompitak, Patimaporn
    Senawong, Sansnee
    Upadhya, Avishek
    Toh, Zheng Quan
    Licciardi, Paul V. V.
    Chokephaibulkit, Kulkanya
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [26] Pregnant Women's Opinions on the COVID-19 Vaccination in Pregnancy
    DesJardin, Marcia
    Raff, Edward
    Baranco, Nicholas
    Mastrogiannis, Dimitrios
    [J]. OBSTETRICS AND GYNECOLOGY, 2022, 139 : 87S - 87S
  • [27] Choices facing pregnant women regarding COVID-19 vaccination
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (12) : 2094 - 2094
  • [28] COVID-19 vaccination for pregnant women: strategies for enhanced coverage
    John, Jennifer Britto
    Devanbu, Vinoth Gnana Chellaiyan
    Kandaswamy, Vijayalakshmi
    [J]. INDIAN JOURNAL OF COMMUNITY HEALTH, 2021, 33 (03) : 539 - 540
  • [29] Perspectives on COVID-19 vaccination for pregnant women in South Africa
    Hunter, Mehreen
    Moodley, Jagidesa
    Moran, Neil
    [J]. AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE, 2021, 13 (01) : 1 - 3
  • [30] Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review
    De Brabandere, Larissa
    Hendrickx, Greet
    Poels, Karolien
    Daelemans, Walter
    Van Damme, Pierre
    Maertens, Kirsten
    [J]. BMJ OPEN, 2023, 13 (02):